The physician-scientist and Novartis CEO Vas Narasimhan brings decades of experience shepherding breakthrough medicines safely to patients, a perspective Anthropic says it needs as AI reshapes healthcare.
Anthropic has announced that Vasant 'Vas' Narasimhan has been appointed to its Board of Directors by the Anthropic Long-Term Benefit Trust. This Indian-American physician climbed to the top of one of the world's most powerful drug companies and looks to now brings that rare combination of scientific rigour and regulatory wisdom to one of Silicon Valley's most consequential AI laboratories.
Narasimhan joins Dario Amodei, Daniela Amodei, Yasmin Razavi, Jay Kreps, Reed Hastings, and Chris Liddell on Anthropic's board. With his addition, Trust-appointed directors now form a majority, a structural milestone that underscores Anthropic's commitment to keeping its governance anchored in its public benefit mission.
Who Is Vas Narasimhan?
Born on August 26, 1976, in Pittsburgh, Pennsylvania, Vasant Kalathur Narasimhan is the son of Tamil Nadu-origin Iyengar Brahmin parents who emigrated to the United States in the 1960s and early 1970s. His mother, Gita Narasimhan, was a nuclear engineer at Public Service Electric and Gas Company and later taught physics at Burlington County Community College. His father, Dr. Kalathur Narasimhan, served as Vice President of Research and Development at Hoeganaes Corporation.
-
HC refuses to quash FIR against 2 Muslim students accused of trying to convert Hindu classmate
-
Devastated Outlander fans 'so angry' as they slam show over 'unnecessary' death
-
India's Uber Cup Squad Faces Changes Due to Injury Setbacks
-
Shubhankar Sharma Dominates Boulders Classic with Record-Equalling Round
-
Mumbai's First-Ever Bouldering Coffee Rave, Thailand's Songkran Festival Feast & More To Experience In The City
